Clinical trials
Completed Observational Purpura, Thrombocytopenic, Idiopathic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 5 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 4 |
| 2019 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Bordeaux | 4 |
| Amgen | 3 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 3 |
| Henri Mondor University Hospital | 3 |
| Boston Children's Hospital | 2 |
| First Affiliated Hospital of Suzhou Medical College | 2 |
| Assiut University | 1 |
| Beth Israel Medical Center | 1 |
| Centre Hospitalier Universitaire Dijon | 1 |
| European Research Consortium on ITP | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Purpura, Thrombocytopenic, Idiopathic | 41 |
| Anemia, Hemolytic, Autoimmune | 3 |
| Lupus Erythematosus, Systemic | 3 |
| Thrombocytopenia | 3 |
| Anemia, Aplastic | 2 |
| Autoimmune Diseases | 2 |
| Hemorrhage | 2 |
| Myelodysplastic Syndromes | 2 |
| Primary Immunodeficiency Diseases | 2 |
| Purpura, Thrombocytopenic | 2 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.